(Q43885268)

27 November 2017

title

Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine (English)

1 reference

chemotherapy-induced acral erythema

27 November 2017

main subject

1 reference

E Laack

1

1 reference

27 November 2017

T Mende

series ordinal

2

1 reference

27 November 2017

C Knuffmann

series ordinal

3

1 reference

27 November 2017

D K Hossfeld

series ordinal

4

1 reference

27 November 2017

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

12

1 reference

27 November 2017

page(s)

1761-1763

1 reference

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Vinorelbine: an overview

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Palmar-plantar erythrodysesthesia and cytarabine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Hand-foot syndrome following prolonged infusion of high doses of vinorelbine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013575816870

7 January 2021

Identifiers

DOI

10.1023/A:1013575816870

1 reference

27 November 2017

1 reference